Literature DB >> 7542459

Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning.

A C Lagerkvist1, C Furebring, C A Borrebaeck.   

Abstract

A simple procedure for the generation of human antibody fragments directly from single B cells or B-cell clones is described here. The procedure is based on antigen-specific selection of single human B cells, using antigen-coated magnetic beads and a cellular amplification step based on a culture system involving both EL-4 thymoma cells and anti-CD40 antibodies, presented by CD32-expressing fibroblasts. Nested PCR was applied to rescue V-regions from both single B cells and B-cell clones obtained using the cellular amplification step. This amplification step both increased the cell number as well as activated the cells that amplified mRNA levels, thereby facilitating immortalization by cloning. The V-regions were cloned and expressed as Fab fragments and characterized by biosensor analysis. This approach allowed us to bypass cumbersome hybridoma technology and to obtain human antibody fragments that retained the original VH/VL pairing, a feature of importance when studying, e.g., the V-gene usage in various human diseases and in normal B-cell repertoires.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542459

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  18 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

Authors:  J A Coronella; P Telleman; T D Truong; F Ylera; R P Junghans
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

3.  Signals sustaining human immunoglobulin V gene hypermutation in isolated germinal centre B cells.

Authors:  K Dahlenborg; J D Pound; J Gordon; C A Borrebaeck; R Carlsson
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 4.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

Review 5.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

6.  The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method.

Authors:  Alison M Clargo; Ashley R Hudson; Welcome Ndlovu; Rebecca J Wootton; Louise A Cremin; Victoria L O'Dowd; Carla R Nowosad; Dale O Starkie; Sophie P Shaw; Joanne E Compson; Dominic P White; Brendon MacKenzie; James R Snowden; Laura E Newnham; Michael Wright; Paul E Stephens; Meryn R Griffiths; Alastair D G Lawson; Daniel J Lightwood
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 7.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

8.  Isolation of human monoclonal antibodies by mammalian cell display.

Authors:  Roger R Beerli; Monika Bauer; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Patrik Maurer; Philippe Saudan; Martin F Bachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

9.  Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein.

Authors:  Roger R Beerli; Monika Bauer; Nicole Schmitz; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Wolfgang A Renner; Philippe Saudan; Martin F Bachmann
Journal:  Virol J       Date:  2009-12-21       Impact factor: 4.099

10.  A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood.

Authors:  Aishun Jin; Tatsuhiko Ozawa; Kazuto Tajiri; Tsutomu Obata; Sachiko Kondo; Koshi Kinoshita; Shinichi Kadowaki; Kazuo Takahashi; Toshiro Sugiyama; Hiroyuki Kishi; Atsushi Muraguchi
Journal:  Nat Med       Date:  2009-08-16       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.